Impact of HLA Matching and HLA Antibodies in Organ Transplantation: A Collaborative Transplant Study View

Author(s):  
Caner Süsal ◽  
Gerhard Opelz
Blood ◽  
2011 ◽  
Vol 118 (23) ◽  
pp. e180-e183 ◽  
Author(s):  
Eduardo Nunes ◽  
Helen Heslop ◽  
Marcelo Fernandez-Vina ◽  
Cynthia Taves ◽  
Dawn R. Wagenknecht ◽  
...  

Abstract Histocompatibility testing for stem cell and solid organ transplantation has become increasingly complex as newly discovered HLA alleles are described. HLA typing assignments reported by laboratories are used by physicians and donor registries for matching donors and recipients. To communicate effectively, a common language for histocompatibility terms should be established. In early 2010, representatives from Clinical, Registry, and Histocompatibility organizations joined together as the Harmonization of Histocompatibility Typing Terms Working Group to define a consensual language for laboratories, physicians, and registries to communicate histocompatibility typing information. The Working Group defined terms for HLA typing resolution, HLA matching, and a format for reporting HLA assignments. In addition, definitions of verification typing and extended typing were addressed. The original draft of the Definitions of Histocompatibility Typing Terms was disseminated to colleagues from each organization to gain feedback and create a collaborative document. Commentary gathered during this 90-day review period were discussed and implemented for preparation of this report. Histocompatibility testing continues to evolve; thus, the definitions agreed on today probably will require refinement and perhaps additional terminology in the future.


1991 ◽  
pp. 17-27
Author(s):  
David W. Gjertson ◽  
Paul I. Terasaki

Author(s):  
T. Leivestad ◽  
E. Vartdal ◽  
E. Thorsby

Blood ◽  
1978 ◽  
Vol 51 (5) ◽  
pp. 781-788 ◽  
Author(s):  
A Brand ◽  
A van Leeuwen ◽  
JG Eernisse ◽  
JJ van Rood

Although the value of HLA matching for the selection of platelet donors for patients refractory to random platelets is beyond doubt, even perfectly matched combinations sometimes fail to give a satisfactory transfusion response. With HLA typing and negative lymphocytotoxicity crossmatches, 35% of the platelet transfusions administered to 15 patients gave disappointing results (29 of 82). Additional crossmatching with the newly developed platelet fluorescence test described in this paper reduced the unexpected transfusion failures to 7% (6 of 82). Five of these failures were observed in one patient. The target of the antibodies detected with this platelet fluorescence test is not yet fully specified. It seems probable that both HLA and platelet-specific non-HLA antibodies were detected. No correlation of the results of platelet transfusions with the presence or absence of leukoagglutinating antibodies was found.


1997 ◽  
Vol 29 (1-2) ◽  
pp. 1467-1468 ◽  
Author(s):  
J. Smith ◽  
H. Ellis ◽  
D. Hunt ◽  
R. Laylor ◽  
A. Danskine ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-9 ◽  
Author(s):  
Kirsten Geneugelijk ◽  
Jeroen Wissing ◽  
Dirk Koppenaal ◽  
Matthias Niemann ◽  
Eric Spierings

Epitope-based HLA matching has been emerged over the last few years as an improved method for HLA matching in solid organ transplantation. The epitope-based matching concept has been incorporated in both the PIRCHE-II and the HLAMatchmaker algorithm to find the most suitable donor for a recipient. For these algorithms, high-resolution HLA genotype data of both donor and recipient is required. Since high-resolution HLA genotype data is often not available, we developed a computational method which allows epitope-based HLA matching from serological split level HLA typing relying on HLA haplotype frequencies. To validate this method, we simulated a donor-recipient population for which PIRCHE-II and eplet values were calculated when using both high-resolution HLA genotype data and serological split level HLA typing. The majority of the serological split level HLA-determined ln(PIRCHE-II)/ln(eplet) values did not or only slightly deviate from the reference group of high-resolution HLA-determined ln(PIRCHE-II)/ln(eplet) values. This deviation was slightly increased when HLA-C or HLA-DQ was omitted from the input and was substantially decreased when using two-field resolution HLA genotype data of the recipient and serological split level HLA typing of the donor. Thus, our data suggest that our computational approach is a powerful tool to estimate PIRCHE-II/eplet values when high-resolution HLA genotype data is not available.


2017 ◽  
Vol 78 ◽  
pp. 97 ◽  
Author(s):  
Peter Jindra ◽  
Thuydung Tu ◽  
Holly Dane ◽  
Lauren E. Clark ◽  
Anna-Marie Young ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document